Paper
Dalton Transactions
1
vacuum before use. Me3SiO3SCF3, Ph3P, Ph2PSiMe3 and δ 148.4 (dm, JFC = 240 Hz, B(o-C6F5)), 140.0 (s, p-C6H5), 139.2
1
1
[NBu4][Ph3SiF2] were purchased from Aldrich and used (dm, JFC = 206 Hz, B(p-C6F5)), 136.9 (dm, JFC = 231 Hz, B(m-
2
3
without further purification. XeF2 and Ph2P(C6F5) were pur- C6F5)), 134.2 (d, JPC = 15 Hz, o-C6H5), 131.5 (d, JPC = 16 Hz,
chased from Apollo Scientific and used without further purifi- m-C6H5), broad, unresolved B(i-C6F5), P(C6F5) and P(i-C6H5)
cation. B(C6F5)3 was purchased from Boulder Chemicals and signals not observed.
used without further purification. All glassware was oven-
dried and cooled under vacuum before use. CH2Cl2, Et2O,
Preparation of [Ph2P(F)(C6F5)][O3SCF3] (3)
n-pentane, and toluene were dried using an Innovative In a glovebox, a 20 mL flask was charged with Ph2P(C6F5)
Technologies solvent purification system. CD2Cl2 (Aldrich) was (221 mg, 626 μmol), a stir bar and 10 mL of CH2Cl2. XeF2
deoxygenated, distilled over CaH2, then stored over 4 Å mole- (106 mg, 626 μmol) was weighed in a separate flask. The XeF2
cular sieves before use. C6D5Br (Aldrich) was deoxygenated solution was carefully transferred to the Ph2P(C6F5) solution
and stored over 4 Å molecular sieves before use. NMR spectra and the colourless effervescing mixture was stirred for 30 min.
were obtained on a Bruker AvanceIII-400 MHz spectrometer.
The solution was then transferred to a vial containing
Me3SiO3SCF3 (140 mg, 626 mmol) and the colourless efferves-
cing solution was stirred for another 30 min. The solvent
Preparation of Ph2P(F)2(C6F5) (1)
A solution of Ph2P(C6F5) (48 mg, 136 μmol) in 5 mL of CH2Cl2 volume was then reduced to approx. 2 mL in vacuo and 10 mL
was added to a solution XeF2 (23 mg, 136 μmol) in 5 mL of of n-pentane was added to the solution resulting in the for-
CH2Cl2, resulting immediately in a colourless, effervescing mation of a white, oily precipitate. The mixture was stirred for
solution. After approx. 1 min, effervescence had ceased and 5 minutes before the precipitate was allowed to settle. The
the solvent volume was reduced to approx. 1 mL in vacuo, then supernatant was decanted and discarded, and the solid was
2 mL of n-pentane were added. Slow evaporation of solvent dried in vacuo and isolated as a white powder (243 mg, 75%,
from the colourless solution yielded diffraction-quality crystals Calcd for C19H10F9O3PS: C, 43.86; H, 1.94%. Found: C, 43.59;
(53 mg, >99%, Anal. Calcd for C18H10F7P: C, 55.40; H, 2.58%. H, 2.23%). 1H NMR (CD2Cl2, Me4Si, 400 MHz): δ 8.14–8.02
Found: C, 55.50; H, 2.82%). 1H NMR (CD2Cl2, 400 MHz, (6H, o,p-C6H5), 7.87 (m, 4H, m-C6H5). 19F NMR (CD2Cl2,
1
Me4Si): δ 8.12 (m, 4H, o-C6H5), 7.61 (m, 2H, p-C6H5), 7.52 (m, 377 MHz, CFCl3): δ −79.1 (s, 3F, CF3), −123.0 (dt, JPF = 1016
4H, m-C6H5). 19F NMR (CD2Cl2, 377 MHz, CFCl3): δ −34.5 (dt, Hz, 4JFF = 17 Hz, 1F, PF), −125.2 (m, 2F, o-C6F5), −133.5 (m, 1F,
4
1JPF = 688 Hz, JFF = 14 Hz, 2F, PF2), −134.2 (m, 2F, o-C6F5), p-C6F5), −155.8 (m, 2F, m-C6F5). 31P{1H} NMR (CD2Cl2, H3PO4,
3
1
3
−153.3 (t, JFF = 20 Hz, 1F, p-C6F5), −162.6 (m, 2F, m-C6F5). 81 MHz): δ 87.1 (dt, JPF = 1016 Hz, JPF = 6 Hz, PF). 13C{1H}
31P{1H} NMR (CD2Cl2, 162 MHz, H3PO4): δ −57.3 (td, JPF
=
NMR (CD2Cl2, 100 MHz, Me4Si): δ 149.4 (dm, JFC = 273 Hz,
1
1
687 Hz, JPF = 14 Hz, PF2). 13C{1H} NMR (CD2Cl2, 100 MHz, p-C6F5), 149.3 (dm, 1JFC = 261 Hz, o-C6F5), 139.6 (dm, 1JFC = 257
3
1
1
4
5
Me4Si): δ 145.8 (dm, JFC = 245 Hz, o-C6F5), 142.5 (dm, JFC
=
Hz, m-C6F5), 139.6 (dd, JPC = 3 Hz, JFC = 2 Hz, p-C6H5), 134.6
272 Hz, p-C6F5), 137.9 (dm, JFC = 250 Hz, m-C6F5), 135.8 (dt, (d, 2JPC = 15 Hz, o-C6H5), 131.4 (d, 3JPC = 16 Hz, m-C6H5), 121.0
1
2JPC = 14 Hz, JFC = 11 Hz, o-C6H5), 133.5 (dt, JPC = 182 Hz, (q, JFC = 321 Hz, CF3), 115.8 (dd, JPC = 114 Hz, JFC = 14 Hz,
3
1
1
1
2
2JFC = 25 Hz, i-C6H5), 133.2 (dt, JPC = 4 Hz, JFC = 1 Hz, i-C6H5), i-C6F5 signal not observed.
4
5
3
4
p-C6H5), 129.1 (dt, JPC = 17 Hz, JFC = 2 Hz, m-C6H5), i-C6F5
signal not observed.
Preparation of [Ph3P(C6F4)P(F)2Ph2][FB(C6F5)3] (4)
A solution of Ph3P (12 mg, 46 μmol) in 2 mL of CH2Cl2 was
added to a solution of 2 (43 mg, 47 μmol) in 2 mL of CH2Cl2
Preparation of [Ph2P(F)(C6F5)][FB(C6F5)3] (2)
A solution of 1 (137 mg, 351 μmol) in 5 mL CH2Cl2 was added instantly producing a white precipitate. The mixture was
to a vial containing a solution of B(C6F5)3 (179 mg, 350 μmol) heated to 40 °C for 15 min, over which time the precipitate
in 5 mL of CH2Cl2, producing a colourless solution. The gradually dissolved to form a colourless solution. The solvent
solvent volume was reduced to approx. 1 mL, then 5 mL of volume was reduced to approx. 0.5 mL in vacuo and 1 mL of
n-pentane were added, resulting in a white precipitate, which Et2O was added, followed by 1 mL of n-pentane. Slow evapo-
was allowed to settle before decanting the supernatant. The ration of solvents from the solution produced colourless,
solid was dried in vacuo and isolated as a white powder diffraction-quality crystals (53 mg, 99%, Calcd for C54H25-
(307 mg, 97%, Anal. Calcd for C36H10BF22P: C, 47.92; H, BF22P2: C, 55.66; H, 2.16%. Found: C, 55.16; H, 2.58%).
1.12%. Found: C, 47.19; H, 1.38%). 1H NMR (CD2Cl2, 1H NMR (CD2Cl2, Me4Si, 400 MHz): δ 8.17 (m, 4H, C6H5), 7.92
400 MHz, Me4Si): δ 8.10 (m, 2H, p-C6H5), 7.97–7.79 (8H, o, (m, 3H, C6H5), 7.79–7.61 (14H, C6H5), 7.55 (m, 4H, C6H5).
1
m-C6H5). 19F NMR (CD2Cl2, 377 MHz, CFCl3): δ −123.4 (dt/br, 19F NMR (CD2Cl2, 377 MHz, CFCl3): δ −36.8 (dt, JPF = 699 Hz,
4
1JPF = 1020 Hz, JFF = 17 Hz, 1F, PF), −124.1 (s/br, 2F, 4JFF = 12 Hz, 2F, PF2), −123.5 (m, 2F, P(C6F4)), −128.5 (m, 2F,
3
P(o-C6F5)), −131.3 (s/br, 1F, P(p-C6F5)), −135.6 (d/br, JFF
=
P(C6F4)), −136.6 (m/br, 6F, B(o-C6F5)), −163.5 (t, 3JFF = 20 Hz, 3F,
16 Hz, 6F, B(o-C6F5)), −153.9 (m/br, 2F, P(m-C6F5)), −161.6 (s/ B(p-C6F5)), −167.9 (m, 6F, B(m-C6F5)), −191.4 (m/br, 1F, BF).
1
br, 3H, B(p-C6F5)), −166.7 (m/br, 6F, B(m-C6F5)), −190.4 (s/br, 11B NMR (CD2Cl2, 128 MHz, BF3·OEt2): δ −0.6 (d, JFB = 65 Hz,
3
1F, BF). 11B NMR (CD2Cl2, 128 MHz, BF3·OEt2): δ 1.9 (s/br, BF). BF). 31P{1H} NMR (CD2Cl2, 162 MHz, H3PO4): δ 16.1 (t, JPF
=
1
31P{1H} NMR (CD2Cl2, 162 MHz, H3PO4): δ 87.2 (d/br, JPF
=
6 Hz, 1P, Ph3P), −58.4 (tm, 1JPF = 699 Hz, 1P, PF2). 13C{1H} NMR
1020 Hz, PF). 13C{1H} NMR (partial, CD2Cl2, 100 MHz, Me4Si): (CD2Cl2, 100 MHz, Me4Si): δ 136.8 (d, JPC = 3 Hz, P(p-C6H5)),
4
2630 | Dalton Trans., 2013, 42, 2629–2635
This journal is © The Royal Society of Chemistry 2013